Improving drug delivery strategies for lymphatic filariasis elimination in urban areas in Ghana

被引:24
作者
Biritwum, Nana-Kwadwo [1 ]
Garshong, Bertha [2 ]
Alomatu, Bright [1 ]
de Souza, Dziedzom K. [3 ]
Gyapong, Margaret [4 ]
Kyelem, Dominique [5 ]
机构
[1] Ghana Hlth Serv, Neglected Trop Dis Program, Accra, Ghana
[2] Ghana Hlth Serv, Res & Dev Div, Accra, Ghana
[3] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana
[4] Dodowa Hlth Res Ctr, Dodowa, Ghana
[5] Taskforce Global Hlth, Decatur, GA USA
来源
PLOS NEGLECTED TROPICAL DISEASES | 2017年 / 11卷 / 05期
关键词
QUALITY IMPROVEMENT; GLOBAL PROGRAM; INDIA; HEALTH; IVERMECTIN; MANAGEMENT; COMMUNITY; COVERAGE; ORISSA; ROUNDS;
D O I
10.1371/journal.pntd.0005619
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The Global Program to Eliminate Lymphatic Filariasis (GPELF) advocates for the treatment of entire endemic communities, in order to achieve its elimination targets. LF is predominantly a rural disease, and achieving the required treatment coverage in these areas is much easier compared to urban areas that are more complex. In Ghana, parts of the Greater Accra Region with Accra as the capital city are also endemic for LF. Mass Drug Administration (MDA) in Accra started in 2006. However, after four years of treatment, the coverage has always been far below the 65% epidemiologic coverage for interrupting transmission. As such, there was a need to identify the reasons for poor treatment coverage and design specific strategies to improve the delivery of MDA. This study therefore set out to identify the opportunities and barriers for implementing MDA in urban settings, and to develop appropriate strategies for MDA in these settings. An experimental, exploratory study was undertaken in three districts in the Greater Accra region. The study identified various types of non-rural settings, the social structures, stakeholders and resources that could be employed for MDA. Qualitative assessment such as in-depth interviews (IDIs) and focus group discussions (FGDs) with community leaders, community members, health providers, NGOs and other stakeholders in the community was undertaken. The study was carried out in three phases: pre-intervention, intervention and post-intervention phases, to assess the profile of the urban areas and identify reasons for poor treatment coverage using both qualitative and quantitative research methods. The outcomes from the study revealed that, knowledge, attitudes and practices of community members to MDA improved slightly from the pre-intervention phase to the post-intervention phase, in the districts where the interventions were readily implemented by health workers. Many factors such as adequate leadership, funding, planning and community involvement, were identified as being important in improving implementation and coverage of MDA in the study districts. Implementing MDA in urban areas therefore needs to be given significant consideration and planning, if the required coverage rates are to be achieved. This paper, presents the recommendations and strategies for undertaking MDA in urban areas.
引用
收藏
页数:23
相关论文
共 50 条
  • [41] Coverage and compliance of mass drug administration (MDA) programme for elimination of lymphatic filariasis in an endemic district of eastern Uttar Pradesh, India
    Bashar, Abu
    Nandekar, Sanket, V
    Shrivastava, Prerna
    Singh, Ravi Nandini
    Srikrishnan, Pushkar
    JOURNAL OF VECTOR BORNE DISEASES, 2023, 60 (03) : 307 - 316
  • [42] Bridging the gap in outreach and compliance with mass drug administration for lymphatic filariasis elimination in an endemic district in Kerala, India: an intervention research approach
    Nandha, B.
    Meenakshy, V.
    Khader, Nazer Abdul
    Vijayakumar, K. N.
    Jambulingam, P.
    HEALTH EDUCATION RESEARCH, 2019, 34 (03) : 300 - 309
  • [43] Implementation challenges and opportunities for improved mass treatment uptake for lymphatic filariasis elimination: Perceptions and experiences of community drug distributors of coastal Kenya
    Njomo, Doris W.
    Kimani, Bridget W.
    Kibe, Lydiah W.
    Okoyo, Collins
    Omondi, Wyckliff P.
    Sultani, Hadley M.
    PLOS NEGLECTED TROPICAL DISEASES, 2020, 14 (12): : 1 - 21
  • [44] Effective Single Drug Treatment of Lymphatic Filariasis through Enhanced Transdermal Delivery of Ivermectin Liposomes using Solid and Dissolving Microneedles
    Devineni, Jyothirmayee
    Pravallika, Ch Durga
    Rani, Boothapati Sudha
    Nalluri, Buchi Naidu
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2020, 54 (03) : S492 - S504
  • [45] Community perspectives on persistent transmission of lymphatic filariasis in three hotspot districts in Ghana after 15 rounds of mass drug administration: a qualitative assessment
    Ahorlu, Collins S. K.
    Koka, Eric
    Adu-Amankwah, Susan
    Otchere, Joseph
    de Souza, Dziedzom Komi
    BMC PUBLIC HEALTH, 2018, 18
  • [46] DILEMMAS OF COMMUNITY-DIRECTED MASS DRUG ADMINISTRATION FOR LYMPHATIC FILARIASIS CONTROL: A QUALITATIVE STUDY FROM URBAN AND RURAL TANZANIA
    Kisoka, William
    Mushi, Declare
    Meyrowitsch, Dan W.
    Malecela, Mwele
    Simonsen, Paul E.
    Tersbol, Britt P.
    JOURNAL OF BIOSOCIAL SCIENCE, 2017, 49 (04) : 447 - 462
  • [47] Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators
    Purushothaman Jambulingam
    Swaminathan Subramanian
    S. J. de Vlas
    Chellasamy Vinubala
    W. A. Stolk
    Parasites & Vectors, 9
  • [48] Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators
    Jambulingam, Purushothaman
    Subramanian, Swaminathan
    de Vlas, S. J.
    Vinubala, Chellasamy
    Stolk, W. A.
    PARASITES & VECTORS, 2016, 9
  • [49] Mass drug administration for lymphatic filariasis elimination amidst COVID-19 pandemic in Odisha, India: A step towards achieving SDG-3
    Sinha, Abhinav
    Mohapatra, Sumegha
    Mohanty, Shubhashisha
    Pati, Sanghamitra
    Sahoo, Prakash Kumar
    TROPICAL DOCTOR, 2022, 52 (04) : 556 - 559
  • [50] Comparative Safety Surveillance of Triple (IDA) Versus Dual Therapy (DA) in Mass Drug Administration for Elimination of Lymphatic Filariasis in Kenya: A Cohort Event Monitoring Study
    Khaemba, Christabel
    Barry, Abbie
    Omondi, Wyckliff P.
    Kirui, Elvis
    Oluka, Margaret
    Parthasarathi, Gurumurthy
    Njenga, Sammy M.
    Guantai, Anastacia
    Aklillu, Eleni
    DRUG SAFETY, 2023, 46 (10) : 961 - 974